scholarly journals Robotic partial nephrectomy for renal cancer

2020 ◽  
Vol 8 (3) ◽  
pp. 071-074
Author(s):  
Danilo Coco ◽  
Silvana Leanza

Introduction: Improved methods are being sought so that the existing low efficiencies can be dealt with for a better solution to the problem of renal cancer. The most promising method is robotic partial nephrectomy which uses a system of automated machines in the treatment of small renal masses as it shows reduced mortality, morbidity, and hospital stay. Aim: To systematically analyze articles to learn about robotic partial nephrectomy and how it has solved some of the current issues in the treatment of renal cancer. Materials and methods: The article systematically reviews 20 articles in the development of a literature review on the emerging technology of robotic partial nephrectomy. The articles are recent and have been published in the last five years. Results and outcome: The studies show the use of robotic partial nephrectomy produces better outcomes in terms of reduced mortality, morbidity, and the number of days a patient stayed in hospital after an operation. Conclusion: The use of robotic partial nephrectomy is the ideal treatment for patients that have renal cancer as it has better outcomes in almost all the researched areas.

Urology ◽  
2012 ◽  
Vol 80 (4) ◽  
pp. 845-851 ◽  
Author(s):  
Julien Guillotreau ◽  
Rachid Yakoubi ◽  
Jean-Alexandre Long ◽  
Joseph Klink ◽  
Riccardo Autorino ◽  
...  

2012 ◽  
Vol 187 (4S) ◽  
Author(s):  
julien guillotreau ◽  
rachid yakoubi ◽  
joseph klink ◽  
riccardo autorino ◽  
jean alexandre Long ◽  
...  

BMJ Open ◽  
2019 ◽  
Vol 9 (6) ◽  
pp. e030965 ◽  
Author(s):  
Joana B Neves ◽  
David Cullen ◽  
Lee Grant ◽  
Miles Walkden ◽  
Steve Bandula ◽  
...  

IntroductionSmall renal masses (SRMs; ≤4 cm) account for two-thirds of new diagnoses of kidney cancer, the majority of which are incidental findings. The natural history of the SRM seems largely indolent. There is an increasing concern regarding surgical overtreatment and the associated health burden in terms of morbidity and economy. Observational data support the safety and efficacy of percutaneous cryoablation but there is an unmet need for high-quality evidence on non-surgical management options and a head-to-head comparison with standard of care is lacking. Historical interventional trial recruitment difficulties demand novel study conduct approaches. We aim to assess if a novel trial design, the cohort embedded randomised controlled trial (RCT), will enable carrying out such a comparison.Methods and analysisSingle-centre prospective cohort study of adults diagnosed with SRM (n=200) with an open label embedded interventional RCT comparing nephron sparing interventions. Cohort participants will be managed at patient and clinicians’ discretion and agree with longitudinal clinical data and biological sample collection, with invitation for trial interventions and participation in comparator control groups. Cohort participants with biopsy-proven renal cell carcinoma eligible for both percutaneous cryoablation and partial nephrectomy will be randomly selected (1:1) and invited to consider percutaneous cryoablation (n=25). The comparator group will be robotic partial nephrectomy (n=25). The primary outcome of this feasibility study is participant recruitment. Qualitative research techniques will assess barriers and recruitment improvement opportunities. Secondary outcomes are participant trial retention, health-related quality of life, treatment complications, blood transfusion rate, intensive care unit admission and renal replacement requirement rates, length of hospital stay, time to return to pre-treatment activities, number of work days lost, and health technologies costs.Ethics and disseminationEthical approval has been granted (UK HRA REC 19/EM/0004). Study outputs will be presented and published.Trial registrationISRCTN18156881; Pre-results.


2017 ◽  
Vol 4 (3) ◽  
pp. 10-19 ◽  
Author(s):  
Anand Mohapatra ◽  
Aaron Potretzke ◽  
John Weaver ◽  
Barrett Anderson ◽  
Joel Vetter ◽  
...  

Treatment modalities for small renal masses (SRMs) include open or minimally invasive radical or partial nephrectomy, and laparoscopic or percutaneous ablations. Members of the Endourological Society were surveyed to evaluate how practitioner and clinical practice characteristics may be associated with the management of SRMs over time. The survey assessed characteristics of urologists (recency of residency and fellowship training, clinical practice type and location, and treatment modalities available) and their management of SRMs over the past year and over the course of the year 5 years prior. Of the 1495 surveys e-mailed, there were 129 respondents (8.6%). Comparing the past year to 5 years prior, there was increasing utilization of robotic partial nephrectomy (p < 0.001) and robotic radial nephrectomy (p = 0.031). In contrast, there was decreasing utilization of open partial nephrectomy (p < 0.001), open radical nephrectomy (p = 0.039), laparoscopic partial nephrectomy (p = 0.002), and laparoscopic radical nephrectomy (p = 0.041). Employment of laparoscopic ablation decreased (p = 0.001), but that of percutaneous ablation did not change significantly. For masses treated with image-guided therapy, there was increasing utilization of microwave ablation (p = 0.008) and decreasing usage of radiofrequency ablation (p = 0.002). Future studies should focus on the most effective treatment modalities based on provider, patient, and tumor characteristics.


2006 ◽  
Vol 175 (4S) ◽  
pp. 229-229
Author(s):  
David C. Miller ◽  
John M. Hollingsworth ◽  
Khaled S. Hafez ◽  
Stephanie Daignault ◽  
Brent K. Hollenbeck

Sign in / Sign up

Export Citation Format

Share Document